ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

N6-methylandenosine-related immune genes correlate with prognosis and immune landscapes in gastric cancer

Huang, Yuancheng; Zou, Yushan; Tian, Yanhua; Yang, Zehong; Hou, Zhengkun; Li, Peiwu; Liu, Fengbin*; Ling, Jiasheng*; Wen, Yi*广州中医药大学; 1; y
Frontiers in Oncology2022-11-29DOI: 10.3389/fonc.2022.1009881
5阅读
引用收藏
分享

摘要

ObjectivesThis study aimed to probe into the significance of N6-methyladenosine (m(6)A)-related immune genes (m(6)AIGs) in predicting prognoses and immune landscapes of patients with gastric cancer (GC). MethodsThe clinical data and transcriptomic matrix of GC patients were acquired from The Cancer Genome Atlas database. The clinically meaningful m(6)AIGs were acquired by univariate Cox regression analysis. GC patients were stratified into different clusters via consensus clustering analysis and different risk subgroups via m(6)AIGs prognostic signature. The clinicopathological features and tumor microenvironment (TME) in the different clusters and different risk subgroups were explored. The predictive performance was evaluated using the KM method, ROC curves, and univariate and multivariate regression analyses. Moreover, we fabricated a nomogram based on risk scores and clinical risk characteristics. Biological functional analysis was performed based on Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathways. The connectivity map was used to screen out potential small molecule drugs for GC patients. ResultsA total of 14 prognostic m(6)AIGs and two clusters based on 14 prognostic m(6)AIGs were identified. A prognostic signature based on 4 m(6)AIGs and a nomogram based on independent prognostic factors was constructed and validated. Different clusters and different risk subgroups were significantly correlated with TME scores, the distribution of immune cells, and the expression of immune checkpoint genes. Some malignant and immune biological processes and pathways were correlated with the patients with poor prognosis. Ten small molecular drugs with potential therapeutic effect were screened out. ConclusionsThis study revealed the prognostic role and significant values of m(6)AIGs in GC, which enhanced the understanding of m(6)AIGs and paved the way for developing predictive biomarkers and therapeutic targets for GC.

学科与关键词

关键词
gastric cancerN6-methyladenosineimmune genesprognostic signaturetumor microenvironment
相关
加载中…
  • Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival
    Yang, Jing; Wu, Zixuan; Wu, Xiaoxi; Chen, Siya; Xia, Xinhua*; Zeng, Jianguo*Frontiers in Oncology, 2022, 12: 1050288.被引 6
  • Mapping the immunological battlefield in gastric cancer: prognostic implications of an immune gene expression signature
    Meng, Xianhong; Wang, Daxiu; Sun, Xueying; Yuan, Jiangfeng; Han, Jiwu*DISCOVER ONCOLOGY, 2023, 14(1): 212.
  • Construction of a novel signature and prediction of the immune landscape in gastric cancer based on necroptosis-related genes
    Li, Zhengtian; Yang, Wenkang; Liu, Dejun; Ye, Weizheng; Du, Gang*; Li, Xi*Scientific Reports, 2022, 12(1): 13290.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-11-29
卷期
第 12 卷
页码
1009881
DOI
10.3389/fonc.2022.1009881
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation [81904139, 81973819, 81904145, 82104602, 81903963]; Collaborative Innovation Team Project of First-Rate Universities and Disciplines and High-level University Discipline of Guangzhou University of Chinese Medicine [2021xk47]; Natural Science Foundation of Guangdong Province [2019A1515011145, 2018A030310614]; Guangdong Medical Science and Technology Research Fund [B2021089, A2020186]; Guangzhou Science and Technology Project [202102020535]; Clinical Research Project of Innovation Hospital in the First Affiliated Hospital of Guangzhou University of Chinese Medicine [2019IIT19]; Innovation Development project of the First Affiliated Hospital of Guangzhou University of Chinese Medicine [2019QN01]

作者

  • H

    Huang, Yuancheng (第一作者)

    1 · guangzhou univ chinese med

  • Z

    Zou, Yushan

    1 · guangzhou univ chinese med

查看全部 9 位作者收起作者
  • T

    Tian, Yanhua

    1 · guangzhou univ chinese med

  • Y

    Yang, Zehong

    1 · guangzhou univ chinese med

  • H

    Hou, Zhengkun

    1 · guangzhou univ chinese med

  • L

    Li, Peiwu

    1 · guangzhou univ chinese med

  • L

    Liu, Fengbin (通讯)

    1 · guangzhou univ chinese med

  • L

    Ling, Jiasheng (通讯)

  • W

    Wen, Yi (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417